Construction work on Tuas Biomedical Park Biologics Manufacturing Facility Expansion located in Singapore, Central Singapore, Singapore commenced in Q1 2024, after the project was announced in Q1 2022. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2026. To learn more about the Tuas Biomedical Park Biologics Manufacturing Facility Expansion project, buy the profile here.
The project involves the expansion of a biologics manufacturing plant with a production capacity of 24,000 liters in Tuas Biomedical Park, Singapore.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of a manufacturing unit
2. Construction of a packing unit
3. Construction of a storage unit
4. Construction of laboratories
5. Construction of related infrastructure
6. Installation of safety system and equipment
Construction on the project is expected to be completed by Q4 2026.
For more details on the Tuas Biomedical Park Biologics Manufacturing Facility Expansion project, buy the profile here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying research used to produce this article.
GlobalData’s Construction Projects database tracks over 220,000 new construction projects valued at >$25m from announcement to completion across all countries and sectors.
